SME · NSESubscribed: 0.22×
Sheel Biotech IPO

Sheel Biotech IPO

Sheel Biotech IPO

Overview

Sheel Biotech IPO is a book build issue of ₹34.02 crores. The issue is entirely a fresh issue of 0.54 crore shares of ₹34.02 crore. Sheel Biotech IPO opens for subscription on Sep 30, 2025 and closes on Oct 3, 2025. The allotment for the Sheel Biotech IPO is expected to be finalized on Oct 6, 2025. Sheel Biotech IPO will list on NSE SME with a tentative listing date fixed as Oct 8, 2025. Sheel Biotech IPO price band is set at ₹59.00 to ₹63.00 per share . The lot size for an application is 2,000. The minimum amount of investment required by an individual investor (retail) is ₹2,52,000.00 (4,000 shares) (based on upper price). The minimum lot size investment for HNI is 3 lots (6,000 shares), amounting to ₹3,78,000. Narnolia Financial Services Ltd. is the book running lead manager and Skyline Financial Services Pvt.Ltd. is the registrar of the issue.

Total Shares

54,00,000

Issue Size

₹34.02 Cr

Price Band

59 – ₹63

Lot Size

2000 shares

Min. Investment

2,52,000

Max. Investment

2,52,000

Open Date

30 Sep, 2025

Close Date

03 Oct, 2025

Allotment

06 Oct, 2025

Listing

08 Oct, 2025

Announced

30 Sep, 2025

Opening Date

30 Sep, 2025

Closing Date

03 Oct, 2025

Basis of Allotment

06 Oct, 2025

Initiation of Refunds

07 Oct, 2025

Credit of Shares

07 Oct, 2025

Listing Date

08 Oct, 2025

Apply via UPI in 5 minutes

Choose your broker • Zero commission on IPO

About Sheel Biotech IPO

Incorporated in November 1991, Sheel Biotech Limited specializes in biotechnology, floriculture, greenhouses, and organic projects.

The company grows and supplies various plants for field crops, fruits, vegetables, and ornamentals through tissue culture and organic farming.

The company manufactures and maintains greenhouses, provides farmer services, and offers training through FPOs.

They also deliver landscaping services to the government and private sectors.

The comp

Sheel Biotech IPO Share Price

Issue Breakdown

Total Issue54,00,000 shares₹34.02 Cr
Fresh Issue0 shares
Offer for Sale0 shares

Shareholding

Pre-Issue1,49,52,550
Post-Issue2,03,52,550

Dilution: 36.1% increase in shares

Sheel Biotech IPO Promoters Holding

Pre-Issue96.99%
Post-Issue71.26%

Sheel Biotech IPO Financial Health

Sheel Biotech IPO Lot Size

Investors can bid for a minimum of 4,000 shares and in multiples of 2,000 shares thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.

ApplicationLotsSharesAmount
Individual investors (Retail) (Min)240002,52,000
Individual investors (Retail) (Max)240002,52,000
S-HNI (Min)360003,78,000
S-HNI (Max)7140008,82,000
B-HNI (Min)81600010,08,000

(All values in CR)

Sheel Biotech IPO Valuations

The market capitalization of Sheel Biotech IPO is ₹128.22 Cr. KPI as of Mon, Mar 31, 2025.

MetricValue
ROE13.59
ROCE16.34
Debt/Equity0.32
RoNW13.59
EBITDA Margin14.71
Price to Book Value1.26

(All values in CR)

Sheel Biotech IPO Strength & Risk

+Strengths

Sheel Biotech IPO Strength:

  • Diversified operations in tissue culture, organic farming, landscaping, FPO training, and greenhouses.

  • ISO-certified and recognized lab with large-scale plant production capacity.

  • Established presence across multiple states with government and private sector clients.

  • Experienced promoters with strong domain expertise and international exposure.

  • Focus on farmer empowerment, skill development, and sustainable agricultural practices.

!Risks

Sheel Biotech IPO Risk:

  • Pending litigations and land acquisition disputes may impact operations.

  • Dependence on timely delivery of government projects could affect revenue.

  • Heavy reliance on top suppliers exposes business to supply chain risks.

  • Absence of long-term contracts; revenues dependent on repeat orders.

  • First-time public issue with no prior trading history; market for shares uncertain.

Sheel Biotech IPO Subscriptions Status

Sheel Biotech IPO subscribed 0.22 times. The public issue subscribed 0.35 times in the individual investors category, 0.02 times in QIB (Ex Anchor), and 0.17 times in the NII category by October 1, 2025 3:49:19 PM (Day 2).

Investor CategorySubscription (times)Shares OfferedShares bid forTotal Amount (Rs Cr.)
Anchor1.0015,24,00015,24,0009.601
QIB (Ex Anchor)0.0210,26,00016,0000.101
Non-Institutional Buyers0.177,74,0001,30,0000.819
bNII (bids above ₹10L)0.145,16,00072,0000.454
sNII (bids below ₹10L)0.222,58,00058,0000.365
Individual Investors (IND category bidding for 2 Lots)0.3518,04,0006,36,0004.007
Total0.2236,04,0007,82,0004.927

Sheel Biotech IPO GMP

Sheel Biotech SME IPO last GMP is ₹0, last updated Oct 1st 2025 02:53 PM. With the price band of 63.00, Sheel Biotech SME IPO's estimated listing price is ₹63 (cap price + today's GMP).The expected percentage gain/loss per share is 0.00%.

00.0%

Last updated 01 Oct, 2025 · Source: aggregated grey-market dealers

DateIPO PriceGMPSub2 SaudaEst. ListingEst. ProfitUpdated
01 Oct, 202563₹0-₹63 (0.00%)-01 Oct, 2025
30 Sep, 202563₹0---30 Sep, 2025
29 Sep, 202563₹0-₹63 (0.00%)-29 Sep, 2025
28 Sep, 202563₹57600₹68 (7.94%)1000028 Sep, 2025
27 Sep, 202563₹57600₹68 (7.94%)1000027 Sep, 2025
26 Sep, 202563₹0-₹63 (0.00%)-26 Sep, 2025

Disclaimer: GMP is an unofficial signal from grey-market dealers and is not regulated by SEBI. Use it alongside subscription data and other research for informed decision-making.

How to Apply for Sheel Biotech IPO

1

Login to Your Trading App

Open Zerodha, Upstox, Groww, Angel One, or any brokerage app.

2

Go to IPO Section

Find Sheel Biotech IPO under the IPO section. Select it and enter your bid details — choose lot size and price (cut-off price recommended).

3

Enter UPI ID and Submit

Provide your UPI ID linked to your bank account and submit the application.

4

Approve Mandate on UPI App

Open your UPI app (Google Pay, PhonePe, Paytm, BHIM) and approve the IPO payment request.

5

Application Confirmed

Your funds will be blocked in your account until the IPO allotment process is completed.